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Abstract
Background: Aneuploidy, or abnormal chromosome numbers, severely alters cell physiology and is widespread in
cancers and other pathologies. Using model cell lines engineered to carry one or more extra chromosomes, it has
been demonstrated that aneuploidy per se impairs proliferation, leads to proteotoxic as well as replication stress
and triggers conserved transcriptome and proteome changes.
Results: In this study, we analysed for the first time miRNAs and demonstrate that their expression is altered in
response to chromosome gain. The miRNA deregulation is independent of the identity of the extra chromosome
and specific to individual cell lines. By cross-omics analysis we demonstrate that although the deregulated miRNAs
differ among individual aneuploid cell lines, their known targets are predominantly associated with cell development,
growth and proliferation, pathways known to be inhibited in response to chromosome gain. Indeed, we show that up
to 72% of these targets are downregulated and the associated miRNAs are overexpressed in aneuploid cells, suggesting
that the miRNA changes contribute to the global transcription changes triggered by aneuploidy. We identified
hsa-miR-10a-5p to be overexpressed in majority of aneuploid cells. Hsa-miR-10a-5p enhances translation of a
subset of mRNAs that contain so called 5’TOP motif and we show that its upregulation in aneuploids provides
resistance to starvation-induced shut down of ribosomal protein translation.
Conclusions: Our work suggests that the changes of the microRNAome contribute on one hand to the adverse
effects of aneuploidy on cell physiology, and on the other hand to the adaptation to aneuploidy by supporting
translation under adverse conditions.
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Background
A balanced karyotype is essential for cell viability and there-
fore aneuploidy, characterized by unbalanced changes in
chromosome numbers and sub-chromosomal structural
variations, has often profound detrimental consequences
for cell physiology. In humans, aneuploidy is the major
cause of spontaneous abortions and the few trisomies
compatible with survival result in severe developmental
defects [1]. Aneuploidy in somatic cells is frequently associ-
ated with cancer, as 70% of haematopoietic and 90% of solid
cancers show an abnormal karyotype [2, 3]. Recently
developed aneuploid model systems in several different
species have accelerated research on the effects of
aneuploidy per se. The physiological changes in response to
an unbalanced karyotype are multifold, including impaired
proliferation, replication stress and proteotoxic stress that is
characterized by changes in protein stoichiometry, reduced
protein folding capacity and by activation of autophagy
[4–13]. The physiological response to aneuploidy goes
hand in hand with a transcriptional response that is
manifested in a conserved pathway deregulation [14, 15].
What triggers these changes in gene expression and how
exactly this specific response is modulated has not been
clarified so far.
Given that the triggers of the transcriptional deregula-
tions remain unclear, we asked whether microRNA
(miRNA) regulation is involved in the response to
aneuploidy. MiRNAs are small non-coding RNA mole-
cules that posttranscriptionally modulate gene expres-
sion of over 60% of protein coding genes [16]. The
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regulatory function of miRNAs is mediated by their
binding to the target 3’untranslated region (UTR) via
partially complementary sequences, thereby inducing
translational repression and/or mRNA decay. Alterna-
tively, some miRNAs bind to sites within the coding
region or the 5’UTR [17, 18]. This binding can poten-
tially stabilize the mRNA or enhance its translation [19].
One mRNA can be affected by multiple miRNAs that
cooperatively translationally repress or degrade the
target mRNA or compete for target regulations [20]. In
turn, single miRNA can repress hundreds of mRNAs
and lead to large-scale transcriptome changes that for
example play a key role in stem cell differentiation [21].
Moreover, the complex miRNA-target network allows to
fine-tune diverse cellular processes by modulating the
amount of transcripts translated particularly upon stress
conditions or changes in the environment [22, 23].
In the disease context such as in cancer, alterations of
miRNA expression are common and specific miRNA
deregulation profiles are sufficient to distinguish
cancerous from non-cancerous tissues and to predict
invasiveness and aggressiveness of various cancers [24–26].
The widespread miRNA deregulation in cancers has been
attributed to genomic copy number changes. For instance,
a gain of chromosome 1q relates to miRNA expression
changes in cervical cancer [27] and downregulation of let-7
family was associated with copy number changes in medul-
loblastoma, breast and ovarian cancer [28]. In some
cancers, deregulated miRNAs promote genomic and
chromosomal instability by targeting the mitotic checkpoint
or DNA damage repair components [29, 30]. Yet, beyond
these few examples, we lack a deeper understanding of how
aneuploidy in cancer and miRNAs expression changes are
linked. Moreover, the relation of miRNA and aneuploidy
per se has not been studied so far.
We asked whether aneuploidy affects miRNA abun-
dance and analysed the phenotypic consequences of
miRNA changes in aneuploid cells (Fig. 1a). To this
end, we used a series of human trisomic and tetrasomic
cell lines that very previously constructed in our labo-
ratory by micronuclei-mediated chromosome transfer
into diploid, chromosomally stable human cell lines
HCT116 and RPE1 ([12], for further details see Methods).
By transferring the individual chromosome, we obtained
homogeneous population with a defined aberrant karyo-
type. Our model cell lines therefore allow study the
general consequences of chromosome gain by direct com-
parison of different trisomies and tetrasomies to their iso-
genic parental cells. Using this model system, we found
that chromosome gains strongly deregulate the expression
of more than 25% of miRNAs, although only a few indi-
vidual miRNAs were commonly altered among different
aneuploidies. Most of the identified miRNA deregulations
negatively affect cell growth and proliferation, thus
suggesting that miRNAs suppress proliferation of aneu-
ploid cells. We identified miRNA hsa-miR-10a-5p to be
overexpressed in majority of analysed cell lines. This
miRNA acts through both the canonical 3’UTR target-
ing as well as via the 5’UTR of target mRNAs. We show
that the alternative 5’UTR targeting provides the aneu-
ploid cells with resistance to starvation by ensuring sus-
tained translation of ribosomal mRNAs upon serum
withdrawal. Our analysis of the global miRNAome
changes in response to chromosome gain reveals a
complex interplay of the gene expression regulatory
mechanisms that shape the global transcriptome and
proteome dynamics in aneuploid cells.
Results
Deregulation of miRNAome in human aneuploid model
cell lines
To determine the effects of chromosome gain on
miRNA expression in human cells, we used a series of
cells derived from HCT116 and RPE1 cell lines that
contain one or more extra copies of different chromo-
somes ([5, 9, 12], Fig. 1a, see Methods for more details).
Following cell lines were subjected to small RNA
sequencing: four HCT116- derived cell lines that gained
chromosome 3, 8, 5 or 18, respectively, the parental
HCT116 cell line, three RPE1- derived cell lines trisomic
for chromosome 7, 21, cell line trisomic for both
chromosome 5 and 12 and the parental RPE1 cell line.
The miRBase repository [31], where 1881 mature human
miRNAs are listed to date, was used as the miRNA data
source for mapping. Mapping of the raw sequences to
the human genome and subsequent identification of
miRNAs with mirdeep2 [32] resulted in at least 554 and
up to 719 identified mature miRNAs in the sequenced
cell lines (Table 1).
While the numbers of identified miRNAs were similar
for all sequenced aneuploid cell lines, the extent of
miRNA deregulation differed. We analyzed the differential
miRNA expression in aneuploid cell lines in comparison
to their diploid counterparts by applying DESeq2 for
normalization and statistical testing [33]. Since miRNAs
with very low expression levels are characterized by low
read counts and an inherent large variability on the loga-
rithmic scale, these miRNAs were pre-filtered [33]. This
filtering for miRNAs with a read count greater than 10
reduced the number of identified miRNAs to 231–293
(Table 2). Using this dataset, we then determined the
significantly deregulated miRNAs as miRNAs with the
aneuploidy/diploid log2 fold change +/− 0.6 at adjusted
p-value < 0.05. We identified from 23 (in RPE1* 21/3)
to 74 (in RPE1 5/3 12/3 and HCT116 5/4) signifi-
cantly deregulated miRNAs (Table 2). The percentage
of deregulated miRNAs ranged from 10% (in RPE1*
21/3) up to 31.2% (in RPE1 5/3 12/3). There was only
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Fig. 1 miRNAome in aneuploid model cell lines. a Schematic summary of the work flow. b Heat map of significantly altered miRNAs in seven
different aneuploid cell lines (adjusted p-value <=0.05). Blue indicates downregulation, red upregulation. Row and column dendrograms show
Euclidean distance between miRNA expression profiles and cell lines, respectively. Commonly deregulated miRNA clusters are highlighted by
black lines. c miRNA expression profile of miRNA cluster upregulated in all HCT116-derived aneuploid cell lines. d miRNA expression profile of
miRNA cluster containing hsa-miR-10a-5p and hsa-miR-139-5p that are upregulated in 5 out of 7 sequenced aneuploid cell lines (red line).
Grey lines indicate miRNAs in the same cluster that are not commonly deregulated. e miRNA expression profile of miRNA cluster containing
hsa-miR-374b-5p that is down regulated in 6 out of 7 sequenced aneuploid cell lines (red line). Grey lines indicate miRNAs in the same cluster
that are not commonly deregulated. Cell lines were ordered according to Euclidean distance. Asterisks indicate cell lines with H2B-GFP
Table 1 Detected mature miRNAs
HCT116 HCT116*v (with H2B-GFP) RPE1 RPE1* (with H2B-GFP)
control 5/4 18/3 c2 control 3/3 c11 8/3 c7 control 5/3 12/3 control 7/3 21/3
mature miRNAs in mirBase 1881
miRNAs detected by mirdeep2 719 554 592 747 572 562 650 628 647 663 646
miRNAs detected in every sample 626 486 510 647 485 490 566 564 562 575 564
The asterisk in the cell line name marks the presence of H2B-GFP
Dürrbaum et al. BMC Genomics  (2018) 19:197 Page 3 of 17
a weak correlation between the percentages of
deregulated miRNAs with the amount of extra DNA
(Additional file 1: Figure S1). Thus, gain of even a
single chromosome deregulates up to one third of
cellular miRNAs.
Cell line specific and general miRNA deregulation in
response to aneuploidy
Comparison of the significantly altered miRNAs in
aneuploid cell lines revealed a pattern of miRNA
expression changes largely distinct for each specific cell
line (Fig. 1b). The Euclidean distance clustering was
not defined by the parental cell type, but rather by dis-
tinct and cell line specific miRNA expression clusters
individual for each aneuploid cell line. HCT116 5/4
showed the most prominent clusters of down- and up-
regulated miRNAs and appeared as an outlier in the
Euclidean distance cluster. The upregulated miRNA
cluster in HCT116 5/4 partially overlapped with the up-
regulated miRNAs in RPE1 5/3 12/3; among them most
prominently the miRNA family miR-192/215, the
nearby located miR-194 and miRNAs hsa-miR-29b and
hsa-miR-29c, which are encoded in a cluster on chromo-
some 1. Only a few similarities were found among different
cell lines. For instance, hsa-miR-21-5p and hsa-miR-24-2-
5p showed similar upregulation in all HCT116-derived cell
lines (Fig. 1c). Moreover, five out of seven sequenced
aneuploid cell lines shared the upregulation of hsa-miR-
139-5p and hsa-miR-10a-5p (Fig. 1d). The latter upregula-
tion did not affect the entire miRNA family and seems to
be specific for the individual miRNA: while hsa-miR-
10a-5p was upregulated in five out of seven of the ana-
lyzed cell lines, the family member hsa-miR-10b-5p was
upregulated only in RPE1 5/3 12/3. Only a few globally
downregulated miRNAs were identified, such as hsa-
miR-374b-5p that was downregulated in all cell lines
except RPE1 5/3 12/3 (Fig. 1e).
The presence of extra chromosomes in cells generally
leads to an elevated expression of the genes that are
located on the supernumerary chromosomes; thus the
abundance of transcripts scales with the gene copy
numbers [6, 12–15, 34, 35]. To determine whether this
holds also true for miRNA expression, we ordered the
miRNAs according to their chromosome location. We
then compared the distribution of the miRNA expression
from the trisomic/tetrasomic chromosomes to miRNA
expression from the disomes and tested whether the
elevated expression occurred just by chance. The
chromosome-specific miRNA expression was significantly
higher than the disomic miRNA expression only for
RPE1* 7/3, RPE1* 21/3 and for the miRNAs encoded on
chromosome 5 in RPE1 5/3 12/3 (Fig. 2a–c). In all other
aneuploid cell lines, the miRNA expression distribution
did not increase significantly with the number of chromo-
some copies (Fig. 2c–g, Additional file 2: Table S1). In
addition, the median miRNA expression differed from
the expected levels even for some disomic chromosomes
in several cell lines (Additional file 1: Figure S2A). For
instance, the median expression of miRNAs encoded on
chromosome 11 and 17 were significantly increased in
HCT116 5/4 despite their disomic status that was
confirmed by DNA sequencing. Taken together, gain of
even a single chromosome leads to strong deregulation of
up to 30% of miRNAs. The largely increased abundance of
the deregulated miRNAs cannot be explained by the
chromosome copy number changes.
Effects of the deregulated miRNAome on transcriptome
We asked to what extent the mRNA expression changes
in response to aneuploidy can be explained by miRNA
deregulation. The transcriptome of HCT116 5/4,
HCT116* 8/3 c7, RPE1 5/3 12/3 and RPE1* 21/3 was
sequenced. The percentage of deregulated mRNAs (log2
fold change +/− 0.6, adjusted p-value < 0.05) highly
differed among the cell lines, with 3.3% in RPE1* 21/3,
16.6% in RPE1 5/3 12/3, 3.0% in HCT116* 8/3 c7 and
20.8% in HCT116 5/4 (Table 2). To model the miRNA-
target network, we retrieved reported miRNA targets
from miRTarBase (v6.1) for all deregulated miRNAs of
each cell line [36]. We then filtered these miRNA targets
for those that were altered in response to aneuploidy.
Although in principle each target can be affected by
several miRNAs, we simplified the complex miRNA-
mRNA relation and filtered for pairs of individual
Table 2 Number of deregulated miRNAs and mRNAs in aneuploid cell lines
HCT116 RPE1
5/4 18/3 c2 *3/3 c11 *8/3 c7 5/3 12/3 *7/3 *21/3
miRNAs with a mean count ≥ 10 249 280 279 293 237 247 231
Significantly deregulated miRNAs log2 Fold Change 0.6–0.6 (padj. < 0.05) 74 57 27 44 74 33 23
Percentage of significantly deregulated miRNAs 29.7 20.4 9.7 15.0 31.2 13.4 10.0
mRNAs with a mean count ≥ 10 13,887 n.a. n.a. 13,873 13,278 13,101 13,101
Significantly deregulated mRNAs log2 Fold Change 0.6–0.6 (padj. < 0.05) 2885 n.a. n.a. 410 2210 434 434
Percentage of significantly deregulated mRNAs 20.8 n.a. n.a. 3.0 16.6 n.a. 3.3
Cell lines with * contain H2B-GFP
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deregulated mRNA targets that were inversely expressed
relative to the individual corresponding miRNAs. This ana-
lysis revealed that 38% of mRNAs that are deregulated in
HCT116 5/4 are potentially targeted by the deregulated
miRNAs, as judged by their inverse expression, 24% in
RPE1* 21/3, 27% in RPE1 5/3 12/3 and only 4.8% HCT116*
8/3 c7 (Table 3). Thus, under these approximations, only a
minor fraction of the mRNA changes in response to aneu-
ploidy might be directly influenced by miRNA regulation.
Deregulated miRNAs negatively affect cell cycle
associated pathways
To determine which cellular functions are affected by
the changes in the miRNAome in aneuploid cells, we
performed functional analysis based on the manually
curated knowledge base of Ingenuity Pathway Analysis [37],
where the miRNA annotations are derived from their
published functional roles, independently of their validated
and predicted targets. Pathway “Cell Cycle” was affected in
all aneuploid cell lines and additional four molecular and
cellular functions affected by the deregulated miRNAs were
shared in at least five out of seven aneuploid cell lines
(Fig. 3a). The miRNAome of HCT116* 3/3 showed less
functional associations and a low number of involved miR-
NAs, although pathways “Cellular Development” and “Cell
Cycle” were also affected (Fig. 3a).
We employed IPA to infer an activation state of the
biological functions as an activation z-score. The IPA
activation z-score is a quantitative measure of the
predicted effect of the deregulated miRNAome on a bio-
logical function [38]. It is calculated based on the direc-
tion of miRNA deregulation and the literature-derived
positive or negative effects of these miRNAs on a bio-
logical function. The available miRNA dataset allowed to
retrieve the z-score for the sub-functional annotation
terms defined by IPA within the categories “Cell Death
and Survival”, “Cellular Development, Cellular Growth
and Proliferation”, “Cellular Growth and Proliferation”
and “Cellular Movement” (Fig. 3b). The effect of the
deregulated miRNAome was mostly negative, as the
sub-functional annotation terms within the four parent
categories were predicted to be inhibited or deactivated
in HCT116 18/3, HCT116 5/4 and RPE1* 7/3. The acti-
vation z-score of HCT116* 3/3 miRNA deregulation
predicted the changes for the category “Cell Death and
Survival”, which is in concordance with the identity of
the five top molecular and cellular functions (Fig. 3).
Therein, “apoptosis” was predicted to be activated with a
z-score of 1.8 and 2 and “cell death” as well as “necrosis”
with a z-score of 1.5 and 1.4, respectively. Thus, the
negative impact of miRNA deregulation might be exe-
cuted in HCT116* 3/3 rather via upregulation of “Cell
Death” pathways than by downregulation of “Cellular
Growth and Proliferation” pathways.
To examine the effect of identified miRNAs on cell
cycle, we transfected mimics and inhibitors of the only
two miRNA candidates that were upregulated in at least
five out of seven analysed aneuploid cell lines: miR-10a-
5p and miR-139-5p (Fig. 1b-d). Whereas transfections of
(See figure on previous page.)
Fig. 2 Expression of microRNAs encoded on the aneuploid chromosomes compared to expression of microRNAs encoded on disomic chromosomes.
Comparison of the expression changes of miRNAs from the aneuploid chromosome and for the miRNAs of the remaining disomic chromosomes in
individual cell lines. a RPE1* 7/3 (note that this cell line spontaneously gained additional copy of chromosome 9 and 12). b RPE1* 21/3, c RPE1 5/3 12/3,
d HCT116 5/4, e HCT116 18/3 clone 2, f HCT116* 3/3 clone 11, g HCT116* 8/3 clone 7, and h Expression fold changes of miRNAs of all aneuploid
chromosomes from all analysed cell lines compared to all disomic miRNAs from all cell lines. i Representative blot of the expression changes
of miRNAs on each individual chromosome for RPE1 12/3 5/3. Blots for the remaining cell lines are in in Additional file 1: Figure S2. For all
blots: Each blue dot represents a microRNA, the log2 fold change expression is always normalized to the expression levels of the corresponding
parental cell line. Boxplot present 75%, 50% and 25% quantile; the median values are shown. Red dotted lines marked log2 of 2-fold change
(0.67). Significance was tested with Mann-Whitney-Wilcoxon test (marked with red asterisk in panel i). Cell lines with * contain H2B-GFP
Table 3 Numbers of targets of deregulated miRNAs (DEmiRNAs)
Cell line HCT116
5/4
RPE1 5/3
12/3
RPE1*
21/3
HCT116
8/3 c7
Deregulated mRNAs 3342 2484 788 250
Deregulated miRNAs (DEmiRNA) 74 74 23 44
ALL TARBASE TARGETS
Number of targets of DEmiRNAs
Total miRNA-target
interactions
9111 6487 6036 965
Unique interactions 6644 4605 5078 877
% of those deregulated
on mRNA level
38.3%
(1280)
24.3%
(604)
27.2%
(214)
4.8%
(12)
Targets of DEmiRNAs with inverse expression:
Total interactions 904 406 142 7
Unique interactions 729 345 127 7
TARBASE TARGETS WITH STRONG EVIDENCE
Number of targets of DEmiRNAs
Total miRNA-target
interactions
729 546 496 213
Unique interactions 520 417 431 193
% of those deregulated
on mRNA level
4.0%
(133)
2.7%
(68)
4.0%
(20)
2.8%
(6)
Targets of DEmiRNAs with inverse expression:
Total interactions 154 54 20 3
Unique interactions 93 40 13 3
The asterisk in the cell line name marks the presence of H2B-GFP
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the hsa-miRNA-10a-5p mimics and inhibitors had only
a negligible effect on proliferation and expression of cell
cycle markers (data not shown), we found that inhibition
of miRNA 139-5p indeed decreased the levels of nega-
tive cell cycle regulators CDKN1A (p21) and CDKN1B
(p27) (Fig. 3c). MiRNA-139-5p is located on chromo-
some 11 at 11q13.4 and its expression is downregulated
in a variety of cancers including hepatocellular carcinoma,
gastric cancer, breast cancer and glioblastoma (e.g [39]).
In summary, although the deregulated miRNAs differed
in individual cells lines, we found a striking overlap in
their predicted, largely negative impact on cellular
growth and proliferation.
Integration of miRNA, RNA and protein expression data
confirms the negative effect on cellular development,
cellular growth and proliferation
To illuminate how the miRNAs execute their negative
impact on cellular development, growth and proliferation
in aneuploids, we analyzed their targets. For this purpose
we exploited the fact that complete miRNAome, tran-
scriptome and proteome data were available for three
cell lines (HCT116 5/4, RPE1 5/3 12/3 and RPE1* 21/3,
this work and [12]). In total, we identified 40 aneuploidy-
responsive miRNAs to be associated with the cellular
development, growth and proliferation category (Additional
file 1: Figure S3A). Comparison with experimentally vali-
dated miRNA-target interactions revealed 604 interactions
with 325 unique targets for HCT116 5/4 (Fig. 4a), 238 in
RPE1 5/3 12/3 and 208 in RPE1* 21/3 (Additional file 1:
Figure S3B, C). Chromosome alignment of the miRNAs
revealed no bias for the superfluous chromosome in any of
the cell lines.
To infer the effect of miRNA regulation on experi-
mentally validated targets, we matched the transcrip-
tome and proteome data to the targets of miRNAs
within the cellular development, growth and prolifera-
tion category. Targets were filtered for their expression
changes above or below a threshold ratio of +/− 0.6
(log2 fold change). Only experimentally validated targets
with a potential miRNA relation (that means with inverse
expression to the interacting miRNA) were considered
for the annotation enrichment analysis. Strikingly, the
protein abundance of 72% of the filtered targets was
downregulated in HCT116 5/4, many of them being
known cell cycle and proliferation- associated proteins
(Fig. 4b). This observation holds also true for RPE1
5/3 12/3 and RPE1* 21/3 (Additional file 1: Figure S3D, E).
Thus, the target gene expression analysis substantiates the
predicted activation state of the molecular function and
suggests a global negative effect of the miRNA changes on
cell cycle and proliferation in response to aneuploidy.
Additionally, we performed functional annotation clus-
tering of the miRNA targets with the DAVID functional
annotation tool. This analysis confirmed the cell cycle
functions as the most affected cluster (Additional file 3:
Table S2). Among the deregulated targets in HCT116 5/
4 we found key players of proliferation, such as the
mitotic checkpoint serine/threonine kinases (BUB1), cell
division cycling 20 (CDC20), cyclin-dependent kinase 4
(CDK4), checkpoint kinase 1 (CHEK1), high motility
group A2 (HMGA2) and regulator of chromosome
condensation (RCC2) (Fig. 4b). Cell cycle associated fac-
tors were also targeted in RPE1 5/3 12/3 and RPE1* 21/3,
such as the minichromosome maintenance protein
complex members (MCM2, 3 and 6) and Cyclin E1
(Additional file 1: Figure S3D, E). Immunoblotting of
some of the targets confirmed their downregulation in
response to aneuploidy (Fig. 4c). Taken together,
deregulated miRNAome in aneuploid cells negatively
affects expression of cell cycle factors and thereby may
contribute to the proliferation defect observed in
aneuploid model cell lines.
Hsa-miR-10a-5p activity is increased in human aneuploid
model cell lines
While the majority of deregulated miRNAs were not
shared among aneuploid cell lines, the miRNA hsa-miR-
10a-5p was significantly upregulated in five out of seven
aneuploid cell lines. Quantitative real-time PCR of 18
different aneuploid model cell lines (for details see
Material and Methods) revealed that the mean expression
of hsa-miR-10a-5p was significantly increased above the
levels of the parental cell line in 7 out of 18 cell lines and
elevated in additional 8 cell lines (Fig. 5a). Interestingly,
the trisomies of chromosome 13, 18 and 21 that are
compatible with survival in a whole organismal context
(Patau, Edwards and Down syndrome, respectively)
(See figure on previous page.)
Fig. 3 microRNAome of aneuploid cells affects cellular development, growth and proliferation. a Top ten cellular and molecular functions affected by
the deregulated microRNAs in individual aneuploid cell lines (in alphabetical order bottom-to-top). The dot size and colour outlines the individual data
and indicates the number of microRNAs that are associated with a specific cellular function. b Subfunctional annotation terms for the four cellular and
molecular functions with the most miRNAs involved (columns). Each graph row contains subfunctional terms for one aneuploid cell line. The size of
the boxes indicate the number of microRNAs associated (y-axis); the colour indicates the predicted activation z-score. Asterisks indicate cell lines with
H2B-GFP. Hep. cells abbreviates hepatoma cell lines. c Immunoblotting of negative cell cycle regulators p21 and p27 upon transfection with inhibitors
and mimics of miRNA139-5p. Left: Example of the immunoblotting, Ponceau S staining was used as a loading control. Right: Quantification based on
four independent experiments, mean and standard deviation are shown
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Fig. 4 microRNA target expression infers functional role of microRNAs. a Number of targets with a strong evidence for each deregulated microRNA
annotated in the “Cellular Development, Cellular Growth and Proliferation” category in HCT116 5/4. The size indicates the number of targets, the
colour shows the significance of microRNA deregulation. The microRNAs are presented according to their chromosomal location. b Target genes
within the “Cellular Development, Cellular Growth and Proliferation” category and their mRNA and protein expression. Selected gene labels indicate
targets with inverse miRNA-target expression that are associated with cell cycle processes. Shape indicates the type of experimental evidence for a
microRNA-target interaction. The colour indicates log2 fold change microRNA expression. c Quantification of the protein levels of miRNA targets
RCC2 and CDK4 in aneuploid and parental control cell lines. The quantification is based on four independent immunoblotting experiments,
mean and standard deviation are shown
a
b c
Fig. 5 hsa-miR-10a-5p levels and activity are increased in aneuploid cel lines. a hsa-miR-10a-5p expression analysed by quantitative real-time
PCR in 18 different aneuploid model cell lines. Boxplots present minimal, maximal and the mean value. Relative expression levels normalized
to corresponding parental cell line is shown. b Luciferase reporter construct to determine hsa-miR-10a-5p endogenous gene repression activity.
Hsa-miR-10a-5p targets its binding site in a synthetic 3’UTR of the Renilla luciferase mRNA resulting in translational repression and/or degradation of
Renilla luciferase mRNA. Renilla luciferase signal is normalized to the internal Firefly luciferase control (see Methods). c Endogenous hsa-miR-10a-5p activity
determined by psiCheck2-10a luciferase reporter assay with hsa-miR-10a-5p binding site in synthetic 3’UTR. HCT116-derived and RPE1-derived cell lines
were transfected with psiCheck2-10a luciferase reporter construct. Luciferase reporter assay was conducted 48 h post transfection. Data represent the
normalized mean values +/− SEM from at least three independent experiments, each performed in triplicates. One-way ANOVA, multiple comparison
correction with Dunnett test. ns = not significant, *P< 0.0332, **P< 0.0021, ***P< 0.0002, ****P< 0.0001. Asterisks indicate the cell lines with H2B-GFP
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showed no or only negligible increase of hsa-miR-10a-5p
expression. The increased expression of hsa-miR-10a-5p
might be a secondary effect of the expression of HOXB3,
in whose locus the miRNA sequence is located. Compari-
son of the hsa-miR-10a-5p and HOXB3 expression levels
in four cell lines revealed that both miR-10a-5p and
HOXB3 were significantly upregulated only in two cell
lines, HCT116 5/4 and RPE1* 21/3, while their levels
were independent in the other cell lines (Additional
file 1: Figure S4). Thus, the upregulation of hsa-miR-
10a-5p cannot be generally explained by increased ex-
pression of the host gene HOXB3.
To determine whether hsa-miR-10a-5p overexpression
affects gene expression in aneuploid cells, we used a
luciferase reporter assay to evaluate its translational re-
pression efficiency (Ørom et al., 2008). The luciferase re-
porter consists of a miR-10a binding site in a synthetic
3’untranslated region (UTR) of the Renilla luciferase
gene (Fig. 5b). The reporter additionally contains a Fire-
fly luciferase gene that allows normalization for transfec-
tion efficiency. Indeed, the normalized luciferase signal
was significantly lower in four out of five tested aneu-
ploid cell lines (Fig. 5c). No changes in luciferase signal
were detected in the HCT116* 8/3 c7 cell line; this is
likely due to a relatively minor increase in the hsa-miR-
10a-5p expression in this cell line (see Fig. 5a).
The target database lists 298 unique target genes for
hsa-miR-10a-5p with only nine previously validated
targets. Only six of the targets were downregulated on
both transcriptome and proteome level in HCT116 5/4
(Additional file 1: Figure S5A). Only two of the 270
hsa-miR-10a targets were downregulated on transcrip-
tome and proteome in both RPE1 5/3 12/3 and RPE1*
21/3 (Additional file 1: Figure S5B,C). This is in
contrast with the other identified deregulated miRNAs,
where majority of the targets showed inversed expres-
sion levels and suggests that the hsa-miR-10a-5p func-
tion in aneuploids might be independent of the 3’UTR
target binding.
Hsa-miR-10a-5p overexpression governs resistance to
translation stress
Next, we considered the fact that hsa-miR-10a-5p binds
also to the 5’UTR downstream of the 5’TOP motif that
is found in mRNAs of ribosomal proteins (RP) and other
mRNAs of translation associated proteins [19]. This
binding results in enhanced translation of RP mRNAs
and alleviates redistribution of RP mRNAs from active
polysomes to inactive RNP complexes upon amino acid
starvation. To analyse the translation efficiency of
mRNAs with the 5’TOP motif, we employed a luciferase
reporter containing the transcriptional start site of the
ribosomal protein S16 (Rps16) and 29 nt of the exon 1
including the 5’TOP motif in the 5’UTR of a luciferase
gene (pS16-wt-luc) (Fig. 6a, [19]). We first determined
the steady state levels of 5’TOP motif mRNA translation
with the pS16-wt-luc luciferase reporter and determined
normalized Firefly luciferase signal similar to the wild
type (Fig. 6b, mock control). Next, we measured the
luciferase activity after overexpression of the hsa-miR-
10a-5p mimic (Additional file 1: Figure S6A, B). Using
the pS16-wt-luc luciferase reporter, we observed that
hsa-miR-10a-5p overexpression enhanced the 5’UTR-
mediated effect on the translation of 5’TOP motif
mRNAs in the parental HCT116 cell line as well as in
three out of four tested aneuploids (Fig. 6b). Thus, the
expression of mRNAs with the 5’TOP motifs is sensitive
to the changes in the hsa-miR-10a-5p abundance.
The translation of mRNAs with the 5’TOP motif is
tightly regulated and cellular stresses such as starvation
result in their translational repression and redistribution
into inactive ribonucleoprotein complexes [40]. We
hypothesized that upregulation of hsa-miR-10a-5p in
aneuploid cell lines might protect the cells from the
translational repression. To test this hypothesis, we
measured the 5’TOP motif mRNA translation via the
luciferase reporter assay in serum-deprived cells. Serum
starvation led to a significant decrease of the luciferase
activity in the parental HCT116 cell line. In contrast, all
aneuploid cell lines were resistant to the translational
reduction of the 5’TOP motif mRNAs (Fig. 6c).
Aneuploidy is known to inhibit pathways related to
ribosome and translation [12–15]. We found that even a
short treatment with cycloheximide, a eukaryotic protein
synthesis inhibitor, induced the expression of hsa-miR-
10a-5p, whereas other stress conditions did not signifi-
cantly affect its expression (Fig. 6d, e). Thus, we propose
that the negative effect of aneuploidy on translation leads
to induction of hsa-miR-10a-5p that may in turn facilitate
survival of aneuploids by its positive effect on translation.
Discussion
Using an integrated approach of large-scale miRNA,
RNA and protein expression data analysis, we document
deregulation of the miRNAome and its consequences in
human aneuploid model cell lines (Fig. 1a). For the first
time, we show that addition of one or two chromosomes
results in extensive genome-wide miRNA expression
changes in human cells (Fig. 1b-e). The data analysis
reveals that the deregulated miRNAome inflicts negative
effects on development, growth and proliferation, and
may thereby contribute to the cellular response to
aneuploidy. Moreover, our evidence suggests that
upregulation of hsa-miR-10a-5p in aneuploid cell lines
might present an adaptation to aneuploidy by providing
means to selectively increase translation.
Karyotype copy number alterations were previously
associated with deregulated miRNA expression in some
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cancers and miRNA coding regions show high frequency
of copy number variations in ovarian, breast, melanoma
and lung cancer [41, 42]. Interestingly, some studies
report no correlation between the copy number status
and miRNA expression in haematopoetic cancer and
acute myeloid leukemia [43, 44]. We observed that the
miRNA abundance does not readily increase according to
the chromosomes copy number (Fig. 2, Additional file 1:
Figure S2), which is in a contrast with mRNA expression
changes that largely scale up with the chromosome copy
number changes [12–15]. The lack of general correlation
between miRNAs abundance and chromosome copy
number changes suggests that the copy number
changes are counteracted by a tight regulation of
miRNA expression.
Aneuploidy remodels the cellular miRNAome, as 9 to
30% of miRNAs were differentially expressed in aneu-
ploids compared to isogenic controls (Tables 1 and 2).
Although the deregulated miRNAs are mostly unique to
the individual aneuploid cell lines, the affected cellular
pathways appear the same: analysis of the cellular func-
tions affected by the deregulated miRNAs identified cel-
lular development, growth and proliferation as common
targets (Fig. 3a, b). The integrated data analysis showed
that the majority of targets, which show an inverse ex-
pression to the deregulated miRNAs, are indeed down-
regulated on mRNA or protein level (Fig. 4, Additional
file 1: Figure S3). Among the downregulated targets are
proteins that are crucial for the cell cycle progression
such as BUB1, CDC20, CDK4 and CHEK1 in HCT116
a
b
c
d e
Fig. 6 5’TOP motif reporter is less sensitive to starvation in aneuploid cells. a Schematic illustration of the pS-16-wt-luc luciferase reporter construct. RPS16
transcriptional start side and 29 nt of Exon 1 including the 5’TOP motif is incorporated into the 5’UTR of luciferase gene. b pS16-wt-luc activity after overex-
pression of hsa-miR-10a-5p. Cells were reverse transfected with hsa-miR-10a-5p mimic or control molecule and 24 h post transfection forward transfected
with pS16-wt-luc and pRL-TK. 72 h post mimic transfection the luciferase assay was conducted. c pS-16-wt-luc activity after starvation. Cells were transfected
as in B and serum- starved for 3 h before the luciferase reporter assay was conducted. Data presents Renilla normalized mean +/− SD values. Two-way
ANOVA, multiple comparison correction with Sidak test. ns = not significant, *P< 0.0332, **P< 0.0021, ***P< 0.0002, ****P< 0.0001. d Abundance of has-
miR-10a-5p determined by quantitative real-time PCR upon prolonged cyclohexamide treatment. e Endogenous hsa-miR-10a-5p activity upon prolonged
cyclohexamide treatment determined by psiCheck2-10a luciferase reporter assay with hsa-miR-10a-5p binding site
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5/4 or Cyclin E1 and RB1 in RPE1-derived aneuploid cell
lines. One of the targets, HMGA2, is strongly downregulated
on both mRNA and protein level in HCT116 5/4 (Fig. 4b).
HMGA2 is a validated target of hsa-miR-26a-5p, let-7a-5p
and hsa-miR-125b-5p, all of which were found to affect cel-
lular growth and proliferation. Downregulation of HMGA2
by hsa-miR-26a negatively affects cell proliferation and has
tumour suppressive effects in gall bladder cancer [45]. An-
other strongly downregulated target is RCC2, which is tar-
geted by hsa-miR-192-5p and hsa-miR-7-5p in HCT1165/4
and RPE1 5/3 12/3 (Fig. 4b, c). RCC2 is essential for mitotic
spindle assembly and recently a novel function of RCC2 for
G1-S transition has been recognized [46–48]. Aneuploidy
impairs proliferation in most model systems [12, 13, 34] and
this is reflected in the conserved transcriptional changes that
include the downregulation of cell cycle associated pathways
[14, 15]. Molecular mechanisms that lead to down-
regulation of pro-proliferative genes and impaired prolifera-
tion in response to chromosome gain are poorly understood.
Based on our results we propose that the miRNA deregula-
tion contributes to the gene expression changes and cell
cycle impairments observed in aneuploid cells.
Only a few miRNAs were commonly upregulated in re-
sponse to aneuploidy, such as miR-139-5p or miR-10a-5p.
Strikingly, many of these upregulated miRNAs are often
downregulated in cancers. For example, hsa-miR-139-5p, a
recognized tumor-suppressing miRNA, is downregulated in
non-small cell lung cancer, gastric cancer, breast cancer and
colorectal carcinoma and often associates with poor progno-
sis [39]. We found that inhibition of miR-139-5p decreases
the expression of cell cycle inhibitors CDKN1A (p21) and
CDKN1B (p27) (Fig. 3c). The opposite direction of expres-
sion changes in model aneuploids was previously observed
for changes of mRNA levels, where the transcriptional re-
sponse to chromosome gain is inversed to the cancer tran-
scriptome [49]. Since gain of chromosomes has a potent
tumor-suppressing effect [50], our findings suggest that the
miRNAs deregulation contributes to this phenotype.
Among the few commonly upregulated miRNAs, we
found hsa-miR-10a-5p and confirmed its increased
endogenous activity using a specific luciferase-based
reporter system (Fig. 6a, b). Only a few hsa-miR-10a-5p tar-
gets showed a concordant downregulation on protein or
mRNA level in human aneuploid model cell lines. These
few affected targets were involved in diverse cellular func-
tions such as cytoskeleton stabilization, transcriptional
regulation and metabolic processes (Additional file 1: Fig-
ure S5, Additional file 4: Table S3). This finding prompted
us to investigate another possible function of hsa-miR-10a-
5p. Hsa-miR-10a-5p binds upstream of the mRNA 5’TOP
motif and affects the translation of mRNAs carrying this
motif. The 5’TOP motif is a cis-regulatory motif present in
transcripts encoding for the translational machinery, mostly
ribosomal proteins [40, 51].
What is the function of the upregulated hsa-miR-10a-5p
in aneuploid cells? Upon nutrition deprivation or cell cycle
arrest the translation of 5’ TOP mRNAs is repressed,
which is indicated by their shift to inactive ribonucleopro-
tein complexes [19]. We observed that the 5’TOP motif
luciferase activity is not repressed upon starvation in
aneuploid cells, in contrast to the diploid parental cell lines,
where the 5’TOP motif luciferase activity is sensitive to
starvation (Fig. 6c-e). As aneuploidy results in a plethora of
cellular stresses, such as proteotoxic stress, metabolic and
replication stress [52], we propose that the upregulation of
hsa-miR-10a-5p in aneuploid cell lines might be a protect-
ive adaption to adverse stress conditions.
Conclusions
Our unique data set describes the aneuploid cells from an
“omics” perspective and allows a global, quantitative
analysis of the consequences of aneuploidy in different cell
lines. Our system demonstrates that an addition of extra
chromosomes largely affects cell physiology on multiple
levels, including marked deregulation of the miRNAome.
The altered miRNAome landscape may explain some of
the transcriptome and proteome changes that occur in
response to aneuploidy and generally emphasizes the
detrimental consequences of chromosome gains.
Methods
Cell lines
The retinal pigment epithelial cell line RPE1 hTERT and
RPE1 hTERT H2B-GFP were a gift from Stefan Taylor
(University of Manchester, UK). The human colorectal
cell line HCT116 was obtained from American Type
Culture Collection (no. CCL-247). HCT116 H2B-GFP
was generated previously by lipofection (FugeneHD,
Roche) transfection of pBOS-H2B-GFP (BD Pharmingen)
according to manufacturer’s protocols [53]. The tetraso-
mic cell line HCT116 5/4 were a kind gift of Minoru Koi
(Baylor University Medical Centre, Dallas, Texas, USA).
All other trisomic and tetrasomic cell lines were generated
by microcell-mediated chromosome transfer as described
previously [5, 9, 12]. Cell lines originating from individual
clonal populations arising from a single cell after by
microcell-mediated chromosome transfer are indicated
with their clone number (c#). The genome sequencing
data of all cell lines are available in the public repository
of NCBI under the accession number GSE102855.
Summary of all cell line information is in Table 4.
RNA sequencing and data processing
Following aneuploid cell lines and parental diploid cell lines
were subjected to RNA sequencing: HCT116, HCT116
H2B-GFP (cell lines containing H2B-GFP will be indicated
by * in the cell line name), HCT116 5/4, HCT116* 8/3
clone7, RPE1, RPE*, RPE1 5/3 12/3, RPE1* 21/3.
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Total RNA was extracted using RNeasy Mini Kit
(QIAGEN). TruSeq RNA library preparation and
Illumina HiSeq2500 sequencing with 25 million 100 bp
single reads per library were performed by the Max
Planck-Genome-Center Cologne, Germany. Subsequently,
sequencing adapters were removed from the raw sequences
with cutadapt and sequencing reads were mapped to the
human genome (hg19) using TopHat (v2.0.10) with the
following parameters: “tophat2 -g1 -G”. RefSeq information
in the GTF file was downloaded from the UCSC genome
browser. featureCounts (v1.4.3) was used to generate the
count matrix with the same GTF file as for the alignment
with the following parameters: “-t exon -g gene_id”.
Normalization and differential expression analysis was
performed using the R/Bioconductor package DESeq2 [33].
For differential expression analysis, trisomic and tetrasomic
cell lines were compared to the parental diploid cell line.
The NGS data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus and are
accessible through GEO Series accession number
GSE102855 (https://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE102855).”
Small RNA sequencing and data processing
Following aneuploid cell lines and parental diploid cell
lines were subjected to small RNA sequencing: HCT116,
HCT116*, HCT116 5/4, HCT116 18/3 clone2, HCT116*
Table 4 List of all cell lines used in the analysis
Cell line name Origin Full cell line name Analysis Remarks
HCT116 Koi laboratory RNA and sRNA sequencing; qPCR Kindly provided by Minoru Koi
HCT116 5/4 Koi laboratory RNA and sRNA sequencing; qPCR Kindly provided by Minoru Koi
HCT116 13/3 c2 MMTC into HCT116 HCT116 13/3 clone 2 qPCR This work
HCT116 13/3 c3 MMTC into HCT116 HCT116 13/3 clone 3 qPCR This work
HCT116 18/3 c1 MMTC into HCT116 HCT116 18/3 clone 1 qPCR This work
HCT116 18/3 c2 MMTC into HCT116 HCT116 18/3 clone 2 sRNA sequencing; qPCR This work
HCT116 21/3 c1 MMTC into HCT116 HCT116 21/3 clone 1 qPCR This work
HCT116 21/3 c3 MMTC into HCT116 HCT116 21/3 clone 3 qPCR This work
HCT116* HCT116 from AATC
introduction of H2B-GFP
HCT116 H2B-GFP qPCR (Kuffer et al., 2013) [53]
HCT116* 3/3 c11 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 3/3
clone 11
sRNA sequencing; qPCR (Passerini et al., 2016) [9]
HCT116* 3/3 c13 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 3/3
clone 13
qPCR (Passerini et al., 2016) [9]
HCT116* 5/3 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 5/3 qPCR (Stingele et al., 2012) [12]
HCT116* 8/3 c5 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 8/3
clone 5
qPCR (Donnelly et al., 2014) [5]
HCT116* 8/3 c6 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 8/3
clone 6
qPCR (Donnelly et al., 2014) [5]
HCT116* 8/3 c7 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 8/3
clone 7
RNA and sRNA sequencing; qPCR (Donnelly et al., 2014) [5]
HCT116* 8/3 c8 MMTC into HCT116 H2B-GFP HCT116 H2B-GFP 8/3
clone 8
qPCR (Donnelly et al., 2014) [5]
RPE1 Taylor laboratory RPE1 hTERT RNA and sRNA sequencing; qPCR Kindly provided by Steven
Taylor
RPE1 5/3 12/3 MMTC into RPE1 RPE1 hTERT 5/3 12/3 RNA and sRNA sequencing; qPCR (Stingele et al., 2012) [12]
Spontaneous gain of
chromosome 12
RPE1* Taylor laboratory RPE1 H2B-GFP hTERT RNA and sRNA sequencing; qPCR Kindly provided by Steven
Taylor
RPE1* 21/3 MMTC into RPE1 H2B-GFP RPE1 H2B-GFP hTERT 21/3 RNA and sRNA sequencing; qPCR (Stingele et al., 2012 [12])
RPE1* 7/3 MMTC into RPE1 H2B-GFP RPE1 H2B-GFP hTERT 7/3 sRNA sequencing; qPCR This work
Spontaneous gain of
chromosomes 9,12
RPE1* 3/3 MMTC into RPE1 H2B-GFP RPE1 H2B-GFP hTERT 3/3 sRNA sequencing; qPCR This work
The asterisk in the cell line name marks the presence of H2B-GFP
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8/3 clone7, HCT116* 3/3, RPE1, RPE*, RPE1 5/3 12/3,
RPE1* 21/3 and RPE1* 7/3.
Total RNA, including small RNAs from 18 nucleo-
tides upwards, was extracted using miRNeasy Mini Kit
(QIAGEN). TruSeq small RNA library preparation and
Illumina HiSeq2500 sequencing with 25 million 100 bp
or 75 bp single reads per library were performed by the
Max Planck-Genome-Center Cologne, Germany. If
necessary, raw sequencing read ends were trimmed for
low quality base calls using the FASTQ quality trimmer
with the following parameters: “-Q33 -t 20 -l 17” [28, 32].
Sequencing adapters were removed with cutadapt. Mapping
to the human genome hg19 and miRNA identification was
performed using mirdeep2 (v2.0.0.8) [32] with the following
commands: “mapper.pl -e -h -i -j -l 18 -m -p hg19 -q” and
“miRDeep2.pl reads.fa hg19.fa genome.arf human_mature_-
rmspace.fa others_mature_rmspace.fa human_hairpin_rm-
space.fa -d -t Human”. The three biological replicates of
aneuploid and the corresponding parental cell line were
analyzed within the same analysis run. For subsequent
normalization and differential expression analysis
miRNA_expressed_all_samples.csv was used as an
input for DESeq2. Differential expression analysis was
performed between aneuploid cell lines and corresponding
parental diploid cell line. To account for sequencing batch
effects, paired replicate information in addition to condi-
tion information was input to the DESeq2 analysis for
HCT116 5/4, RPE1 5/3 12/3 and RPE1* 21/3 and corre-
sponding parental cell lines. The genome sequencing data
of all cell lines are available in the public repository of
NCBI under the accession number GSE102855.
Integrative mRNA, miRNA and target analysis
Data analysis, such as integration and data visualization
was performed using the computing environment R.
Mapping of identifiers as well as genome locations was
performed with BioMart using biomaRt package in R
[54, 55]. miRNA (miRNA) identifiers were retrieved
from miRBase (v21). miRNA target information was
retrieved from miRTarBase (v6.1) [36, 56].
Functional annotation analysis
miRNA differential expression datasets were analyzed
using the Ingenuity Pathway Analysis Software [37].
Core analysis was performed with the differential
expressed miRNAs (log2 fold change +/− 0.6, adjusted
p-value < 0.05) against the Ingenuity knowledge base
considering direct experimentally observed relationships
in human species. Functional annotation analysis results
were exported and visualized in R. Functional annotation
analysis of target genes was conducted using the
Database for Annotation, Visualization and Integrated
Discovery (DAVID v6.8) by applying functional annota-
tion clustering.
Quantitative real-time PCR of miRNAs
Total RNA, including small RNAs from 18 nucleotides
upwards, was extracted using miRNeasy Mini Kit
(QIAGEN). Reverse transcription was performed using
the universal cDNA synthesis kit miRCURY LNA™
(Exiqon) according to manufacturers protocol. UniSp6
RNA spike-in control was added to each sample in equal
amounts. Quantitative PCR was conducted using the
Light Cycler 480 System (Roche Diagnostics) using the
ExiLENT SYBR® Green master mix miRCURY LNA™
(Exiqon) and miRNA specific LNA™ PCR primer sets
(Exiqon) as well as the UniSp6 RNA spike control primer
set (Exiqon). Absolute quantification with an external
standard was performed and negative non-template
controls were included in all experiments. The specificity
of the primer product amplification was confirmed in each
run by melting curve analysis. miRNA expression was
normalized to the control spike RNA and corresponding
diploid miRNA expression.
Luciferase reporters
hsa-miR-10a-5p 3’UTR luciferase reporter (psiCheck2-
10a) was constructed by cloning the complementary
miRNA target sequence in the synthetic 3’UTR of
psiCHECK™-2 Vector (Promega). PCR cloning was
performed with the following primers:
top 5’-CACAAATTCGGATCTACAGGGTAGTTTAAA
CCTAGAGCGGCCGCT-‘3 and.
bottom 5’-CTGACCTATGAATTGACAGCCGCGATC
GCCTAGAATTACTGC-‘3.
pS16-WT luciferase vector containing the transcrip-
tional start site of the ribosomal protein S16 (Rps16) and
29 nt of the exon 1 including the 5’TOP motif was a
kind gift of Anders H. Lund (University of Copenhagen,
Denmark). pRL-TK Renilla vector was a kind gift of
Reinhard Fässler (Max Planck Institute of Biochemistry,
Martinsried).
Endogenous hsa-miR-10a-5p mediated 3’UTR repression
assay
Cell lines were forward transfected with psiCheck2-10a
using Lipofectamine 200 (Thermo Fisher Scientific)
according to manufacturer’s protocol. Cells were
reseeded into 96 well plates 24 h (hrs) post transfection
at 20.000/ well HCT116- derived cell lines and 10.000/
well RPE1 derived cell lines. Luciferase activity was
monitored 48 h post transfection using the Dual-Glo®
Luciferase Assay System (Promega). Renilla luciferase
activity values were normalized to the Firefly luciferase
activity and subsequently to the parental cell line.
Statistical testing and data plotting was performed in
GraphPad Prism 6.
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Hsa-miR-10a-5p mediated 5’TOP motif mRNA translation assay
Cell lines were reverse transfected with miRCURY
LNA™ miRNA Mimic or miRCURY LNA™ miRNA
Mimic Negative Control (Exiqon) at 50 nM using
Lipofectamine 200 (Thermo Fisher Scientific) according
to manufacturers protocol. Cells were forward trans-
fected with the pS16-wt-luc Firefly luciferase reporter
construct and pRL-TK Renilla luciferase control vector
24 h post mimic transfection. Forty-eight hours post
mimic transfection, cells were reseeded into 96 well
plates at 20.000/ well HCT116- derived cell lines and
10.000/ well RPE1- derived cell lines. Luciferase activity
was monitored 72 h post transfection using Dual-Glo®
Luciferase Assay System (Promega). Starvation was per-
formed by replacing the Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% fetal bovine
serum and 1% penicillin/ streptomycin with DMEM
without supplements for 3 h prior measurement of
luciferase activity. Firefly luciferase activity values were
normalized to Renilla luciferase activity and subse-
quently to the parental cell line. Statistical testing and
data plotting was performed in GraphPad Prism 6.
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